Rheacell Gmbh & Co. Kg
Clinical trials sponsored by Rheacell Gmbh & Co. Kg, explained in plain language.
-
Stem cells may heal wounds in 'butterfly skin' disease
Disease control OngoingThis study tests a stem cell treatment (ABCB5+ MSCs) for people with epidermolysis bullosa, a genetic condition causing fragile skin that blisters easily. The goal is to see if the treatment can safely close wounds that won't heal on their own. Participants receive either the ste…
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Butterfly children: stem cell trial offers hope for wound healing
Disease control OngoingThis study tests a stem cell treatment for epidermolysis bullosa, a rare genetic condition causing fragile skin that blisters easily. About 91 participants with severe forms (RDEB or JEB) receive either the stem cells or a placebo through an IV. The main goal is to see if the tre…
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated May 13, 2026 16:01 UTC
-
New hope for hard-to-heal leg ulcers: cell therapy enters final testing
Disease control OngoingThis phase 3 trial tests a topical cell therapy called Allo-APZ2-CVU for chronic venous leg ulcers that haven't healed with standard care. About 250 adults with ulcers between 1 and 25 cm² are enrolled. The goal is to see if the treatment leads to complete wound closure lasting a…
Phase: PHASE3 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated May 08, 2026 12:03 UTC